Takeda Pharmaceutical Co Ltd SEC filings TKPHF
Takeda Pharmaceutical Co Ltd has 710 filings in SEC EDGAR's recent list, going back to Mar 5, 2007. Its latest annual report, Form 20-F, was filed on Jun 17, 2026 for the period ended Mar 31, 2026. The most recent current report (Form 6-K) was filed on Oct 29, 2026.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B2 | Prospectus | Jun 27, 2025 | — |
| FWP | Free writing prospectus | Jun 27, 2025 | — |
| 424B5 | Prospectus supplement | Jun 26, 2025 | — |
| F-3ASR | Filing | Jun 25, 2025 | — |
| 424B2 | Prospectus | Jun 28, 2024 | — |
| FWP | Free writing prospectus | Jun 28, 2024 | — |
| 424B5 | Prospectus supplement | Jun 27, 2024 | — |
| F-3ASR | Filing | Jun 26, 2024 | — |
| S-8 | Employee stock plan registration | Jun 28, 2023 | — |
| S-8 | Employee stock plan registration | Jun 29, 2022 | — |
| S-8 | Employee stock plan registration | Oct 28, 2021 | — |
| 424B2 | Prospectus | Jun 30, 2020 | — |
| 424B2 | Prospectus | Jun 30, 2020 | — |
| FWP | Free writing prospectus | Jun 30, 2020 | — |
| FWP | Free writing prospectus | Jun 30, 2020 | — |
| 424B5 | Prospectus supplement | Jun 25, 2020 | — |
| S-8 | Employee stock plan registration | Jun 25, 2020 | — |
| 424B5 | Prospectus supplement | Jun 25, 2020 | — |
| F-3ASR | Filing | Jun 24, 2020 | — |
| POS AM | Filing | Feb 26, 2020 | — |
| 424B3 | Prospectus | Nov 14, 2019 | — |
| F-4/A | Form f-4/a | Nov 12, 2019 | — |
| F-4 | Form f-4 | Aug 9, 2019 | — |
| F-6 | Form f-6 | Apr 23, 2010 | — |
| F-6EF | Filing | Mar 26, 2008 | — |
| F-6EF | Filing | Mar 20, 2008 | — |
| F-6EF | Filing | Mar 5, 2008 | — |
Showing 27 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TAK (NYSE), TKPHF (OTC)
- Headquarters
- Tokyo, Japan
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1395064
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.